Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
- PMID: 33228963
- DOI: 10.1016/j.ajo.2020.09.015
Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
Comment on
-
Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol. 2020 Nov;219:101-106. doi: 10.1016/j.ajo.2020.06.030. Epub 2020 Jun 28. Am J Ophthalmol. 2020. PMID: 32610049 Review.
-
Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol. 2021 Feb;222:399-400. doi: 10.1016/j.ajo.2020.09.016. Epub 2020 Nov 20. Am J Ophthalmol. 2021. PMID: 33223050 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
